Treatment with recombinant RNase 4 conferred neuromuscular benefit to a transgenic mouse model of ALS, lending rationale for its consideration as a novel ALS therapeutic by promoting neurogenesis and neuronal survival under stress [35]. The gene discussed is RNASE4; the disease is amyotrophic lateral sclerosis.